Purgation with misraka sneha in treating rheumatoid arthritis

clinical study on Virechana karma with Misraka sneha in the management of Amavata. - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069512

Enrollment

Registered

2024-06-26

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: -Participants full fill the diagnostic criteria aged between 20 to 60 years of either gender. -Participants with lakshanas of amavata14. -Participants indicated for virechana. -Participants with diabetes mellitus and hypertension under control. -Participants with madhyama kosta.

Exclusion criteria

Exclusion criteria: -Participants diagnosed with other inflammatory and degenerative joint diseases. -Pregnant and Lactating woman. -Participants with Amavata presenting with complication including joint deformities. -Any other condition interfering the course of treatment.

Design outcomes

Secondary

Measure	Time frame
1.RHEUMATOID FACTOR 2.C-REACTIVE PROTEIN 3.JOINT TENDERNESS 4.VAS SCORETimepoint: 24days	—

Primary

Measure	Time frame
whether the given medicine is effective in causing proper purgation (samyak virikta lakshanas)Timepoint: On the day of purgation	—

Countries

India

Contacts

Public ContactDR Lohith B A

Shri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital

prabhusindhu1512@gmail.com8197479442

Outcome results